Marie Bradley, PhD, MPharm, MScPH, on Apixaban and Warfarin for Stroke Prevention in Patients With NVAF
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular atrial fibrillation.
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a session she recently presented at ADCES21, on the use of SGLT-2 inhibitors in patients with heart failure.
Results of a new study show that women experience gender-specific concerns due to their subcutaneous implantable cardioverter-defibrillators. In this Q&A, Willeke van der Stuijt, MD, highlights those concerns and how you can help minimize them among your patients.
The Consumer Technology Association and Heart Rhythm Society have released new guidance on the best practices for consumers who use wearable devices. Lead author Nassir F. Marrouche, MD, from Tulane University, answers our questions about this new guidance.
The Heart Rhythm Society recently led an international survey of more than 1100 EP professionals to gauge how cardiac arrhythmias are being managed among patients hospitalized with COVID-19. Rakesh Gopinathannair, MD, MA, answers our questions about the survey results.
Hookah is a common tobacco product, especially among youth. A research team aimed to better understand the effects of hookah on thrombogenesis. Lead author Fadi Khasawneh, B.Pharm, PhD, answered our questions about his team’s research.
You may have patients who experience more than 1 social risk factor, and new research shows that these patients are at an increased risk for silent myocardial infarction. Elsayed Z. Soliman, MD, MSc, MS, explains how you can consider identifying and monitoring these patients.
New data are shedding light on the use of NOACs among patients with atrial fibrillation and obesity. Robert Giugliano, MD, explains how he hopes the new research will impact future guideline updates.
Does consuming caffeine in coffee adversely affect individuals with arrhythmia? Eun-Jeong Kim, MD, explains how her latest findings debunk a long-standing myth and how her research can impact the guidance you give patients.
The FDA approved bempedoic acid for the lowering of LDL-C in February 2020. In this Q&A, Pam R. Taub, MD, provides insight into the novel therapy.